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Abstract
Candida sp. are opportunistic fungal pathogens that colonize the skin and oral cavity and, when overgrown under
permissive conditions, cause inflammation and disease. Previously, we identified a central role for the NLRP3 inflammasome
in regulating IL-1b production and resistance to dissemination from oral infection with Candida albicans. Here we show that
mucosal expression of NLRP3 and NLRC4 is induced by Candida infection, and up-regulation of these molecules is impaired
in NLRP3 and NLRC4 deficient mice. Additionally, we reveal a role for the NLRC4 inflammasome in anti-fungal defenses.
NLRC4 is important for control of mucosal Candida infection and impacts inflammatory cell recruitment to infected tissues,
as well as protects against systemic dissemination of infection. Deficiency in either NLRC4 or NLRP3 results in severely
attenuated pro-inflammatory and antimicrobial peptide responses in the oral cavity. Using bone marrow chimeric mouse
models, we show that, in contrast to NLRP3 which limits the severity of infection when present in either the hematopoietic
or stromal compartments, NLRC4 plays an important role in limiting mucosal candidiasis when functioning at the level of
the mucosal stroma. Collectively, these studies reveal the tissue specific roles of the NLRP3 and NLRC4 inflammasome in
innate immune responses against mucosal Candida infection.
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Introduction
Candida sp. are dimorphic fungi that commonly colonize the oral
cavity of adult humans, with overgrowth prevented by competing
commensal bacteria as well as local host immune responses.
Perturbations of the normal oral flora through antibiotic
treatment, for example, or immunocompromised states can lead
to mucosal Candida overgrowth resulting in the development of
oropharyngeal candidiasis (OPC, also known as thrush). Candida
albicans has now been identified as the leading cause of fatal fungal
infections, with mortality rates as high as 50%, and ranks 4th
among all pathogens isolated from bloodstream and nosocomial
infections [1–3]. Host recognition of Candida requires engagement
of surface receptors on innate immune cells, including TLR2 and
Dectin-1 [4–7]. A major consequence of receptor activation is the
induction of pro-inflammatory gene expression including inter-
leukin 1 beta (IL-1b), a zymogen which requires proteolytic
processing by caspase-1 to become biologically active [8–11].
Activation of caspase-1 requires signaling through recently
described protein complexes termed inflammasomes, consisting
of either NOD-like receptor (NLR) molecules or the PYHIN
protein, Absent in melanoma-2 (AIM2) [12–16]. NLRs are
characterized by the presence of a Leucine Rich Repeat domain,
a central NACHT domain involved in oligomerization and
protein-protein interactions, and a CARD or PYRIN domain
[17]. Conformational changes in NLR proteins, resulting from the
introduction of activating stimuli, cause oligomerization of NLR
proteins together with ASC adapters, permitting autocatalytic
cleavage of pro-caspase-1 to an active state capable of cleaving
pro-IL-1b. Although intracellular danger signals and crystalline
compounds such as uric acid crystals, cholesterol crystals, amyloid
and asbestos have been shown to activate the NLRP3 inflamma-
some [18–22], the precise mechanism(s) underlying inflammasome
activation are not defined. Currently, several theories have been
proposed for the molecular mechanisms underlying activation of
the NLRP3 inflammasome including mitochondrial ROS pro-
duction [23], phagosomal or endosomal rupture and cell
membrane disturbances [24–27]. The NLRP3 inflammasome
has been linked to IL-1b responses to pathogen-derived molecules
including bacterial muramyl dipeptide [28] and toxins [20,28], as
well as in response to a range of bacterial, viral and fungal
pathogens, including Candida albicans [6,29]. Another NLR
molecule, NLRC4, also forms an inflammasome capable of
activating caspase-1 and IL-1b cleavage. During some bacterial
infections, such as with Shigella, Salmonella, Pseudomonas or Legionella,
NLRC4 detects inadvertently translocated flagellin or PrgJ rod
protein, a component of the type III secretion system [30–35].
Although limited in vitro studies using NLRC4 deficient macro-
phages or dendritic cells challenged with Candida albicans revealed
no defects in caspase-1-dependent IL-1b responses [29,36,37], the
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role of NLRC4 in live fungal infection models has not been
thoroughly defined.
In this study, we sought to examine the role of other
inflammasome in anti-fungal defenses in vivo. We show that
infection with Candida albicans leads to up-regulation of NLRP3
and NLRC4 expression in the oral mucosa and this induction is
impaired in both NLRP3 and NLRC4 deficient mice. Addition-
ally, we reveal a role for the NLRC4 inflammasome in regulating
resistance to mucosal infection with Candida as well as preventing
systemic dissemination. We show that inflammasome driven IL-1b
responses via both the NLRC4 and NLRP3 inflammasome are
essential for epithelial antimicrobial peptide production, and other
inflammatory responses including IL-18 and IL-17 in response to
Candida infection. Inflammatory cell recruitment to Candida
infected oral mucosa is significantly impaired in NLRC4 deficient
mice compared to wild-type mice. Using bone marrow chimera
mice, we reveal that the activity of NLRC4 is mediated at the level
of the mucosal stroma, in contrast to that observed with NLRP3
which is active in both hematopoietic and stromal compartments.
Collectively our studies show that, in addition to the NLRP3
inflammasome, there is a tissue specific role for the NLRC4
inflammasome in host sensing and immune defense to non-
bacterial pathogens such as Candida albicans.
Results
Regulation of inflammasome expression in oral mucosal
tissues following infection with Candida albicans
During Candida infection, the oral mucosa acts as a physical
barrier to infection as well as the initial tissue to respond to fungal
growth and invasion. To assess the impact of Candida treatment on
the oral mucosa, we monitored gene expression levels in oral
mucosa by quantitative real-time PCR. We first examined the
level of NLR expression in buccal tissues of Candida infected mice
and observed a strong induction of NLRP3 in wild-type mice
following oral challenge with Candida albicans. Induction of NLRP3
was significantly reduced in both Nlrc42/2 and Asc2/2 mice
(Figure 1A). Similarly, NLRC4 was induced in WT mice and
negligible in Nlrp32/2 and Asc2/2 mice (Figure 1B). As expected,
ASC was not induced in any of the strains after Candida infection.
These data indicate that genetic knockdown of a single NLR may
have profound effects on the expression profile of other NLR
proteins and is, to our knowledge, the first evidence of cross-
regulation of NLRP3 and NLRC4.
Candida induced IL-1b in the oral mucosa is dependent
on both NLRP3 and NLRC4
We next assessed the impact of the NLRP3 and NLRC4
inflammasomes on expression levels of members of the IL-1
family. There was a significant difference in the induction of IL-1b
between the WT and Nlrc42/2, Nlrp32/2, and Asc2/2 mice
(Figure 1C). This defect in IL-1b production was confirmed in the
serum of infected mice at 3 days of infection (Figure 1D). Levels of
IL-1R1 expression were similar between WT and Nlrc42/2 or
Asc2/2 mice with reduced induction observed in Nlrp32/2 mice,
although this was not significant (Figure 1E). Induction of IL-1R
antagonist (IL-1Rn) was not significantly different between any of
the inflammasome knockout mice and WT mice (Figure 1F).
Overall, the induction of IL-1R1 and IL-1Rn was minimal
compared to IL-1b in all the infected mice.
NLRC4 protects against mucosal fungal infection and
early dissemination of infection in a murine model of
oropharyngeal candidiasis
Our previous studies demonstrated that NLRP3 signaling is
critical for the prevention of fungal growth as well as dissemination
in a murine model of oropharyngeal candidiasis [6]. A role for the
NLRC4 inflammasome in response to oral fungal challenge has
yet to be characterized. In order to ascertain the impact of loss of
NLRC4 function on disease progression, we infected wild-type
(WT) and Nlrc42/2 mice with Candida albicans as previously
described [6]. Oral fungal burdens were elevated in Nlrc42/2 mice
compared to WT mice by day 7, and persistently higher fungal
burdens were observed to day 21 (Figure 2A). In our model of
persistent, low virulence oral candidiasis, WT mice rarely show
blood borne dissemination of infection, as measured by quanti-
tative fungal burdens in the kidneys (Figure 2B). In contrast,
Nlrc42/2 mice show a significantly increased susceptibility to
dissemination of infection, peaking at day 7 but returning to WT
levels by day 21. In agreement with these findings, Nlrc42/2 mice
also had elevated gross clinical scores, a qualitative measure of oral
infection severity, at all time points (Figure 2C). Survival in the
Nlrc42/2 mice was reduced when compared to WT mice when
infected with a virulent strain of Candida albicans (Figure 2D).
Elevated quantitative fungal colonization was observed in tissues of
the gastrointestinal tract including esophagus, stomach, and small
intestine in Nlrc42/2 mice compared to WT (Figure S1).
These data contrast with studies in Nlrp32/2 mice, in which it
was determined that oral fungal colonization was similar at day 3,
becoming slightly elevated at day 7 and 14, and returning to WT
levels by day 21 (Figure 2A). These mice exhibited elevated levels
of systemic dissemination throughout the 21 day timecourse
(Figure 2B). By day 21, the gross clinical score of both Nlrp32/2
and WT mice were between 0 and 1, indicating minimal signs of
infection, which contrasts the sustained elevated clinical score seen
in Nlrc42/2 mice (Figure 2C). Taken together, our studies imply
that NLRC4 and NLRP3 are differentially functioning in the
innate response to Candida infection, with NLRC4 playing a more
prominent role in the clearance of oral infection.
NLRC4 is required for neutrophil recruitment following
Candida challenge
One of the earliest inflammatory cells that migrate to the site of
microbial infection are neutrophils, and this chemotaxis is
necessary for proper inflammatory responses and anti-microbial
Author Summary
In this manuscript we describe a new role for a group of
molecules termed the ‘‘inflammasome’’ that process key
immune response proteins including interleukin-1-b. In
previous work, we and others have shown that the NLRP3
inflammasome is important in protecting from severe
fungal infections. We now show that, in addition to the
NLRP3 inflammasome, a different inflammasome contain-
ing NLRC4 is also important in protecting against infection
with Candida albicans, and appears to be functioning in
the mucosal lining of the mouth and intestines, rather than
in immune cells. Our research explains a new mechanism
of mucosal immunity to fungal infections and has broad
implications for developing new treatments against fungal
infections, which are a serious cause of illness and death,
particularly in immunocompromised persons. Additionally,
this research may also lead to new ways to identify those
individuals who are at the highest risk for serious fungal
infections.
NLRC4 Inflammasome in Mucosal Candidiasis
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defenses. Given the known capacity for IL-1b to mediate leukocyte
infiltration into infected tissues, we used histology to examine the
impact of inflammasome deficiency on cellular infiltration to the
mucosa of the tongue. By day 2, a robust cellular infiltration was
observed in the dorsal epithelium of a WT tongue, particularly in
areas showing the presence of fungal hyphae and epithelial erosion
(Figure 3A). These cells morphologically appear to have multi-
lobulated nuclei, consistent with neutrophils. In contrast, minimal
cellular infiltration was observed in a tongue from Nlrc42/2
mouse, despite the presence of erosive lesions and fungal hyphae
(Figure 3C). Nlrp32/2 and Asc2/2 tongues exhibited cellular
infiltration, although not to the extent of WT; and these areas of
concentrated cellular infiltrates also correlated with the presence of
fungal hyphae and tissue erosion (Figure 3E, G). Neutrophils have
been implicated in the control of a range of microbial infections,
including Candida [38–40]. Given the presence of significant
cellular infiltration at 2d post infection, we sought to specifically
characterize the extent of neutrophil infiltration in these tissues.
Using a monoclonal antibody shown to specifically stain
neutrophils, we observed significant neutrophil staining in the
outer epithelium of the WT tongue. This immunofluorescent
staining localized to the regions of increased cellularity observed in
the epithelium with PAS/H staining (Figure 3B). Neutrophils were
also observed throughout the sub-mucosal tissue. In agreement
with our finding with PAS/H staining, neutrophil influx into the
Nlrc42/2 was drastically reduced (Figure 3D). As expected, a
significant influx of neutrophils was observed in both Nlrp32/2
and Asc2/2 tongues (Figure 3F, H). Intriguingly, it was observed
that not only was there a reduction in neutrophil infiltration in the
Nlrc42/2 tongue but the neutrophils present failed to infiltrate the
epithelium where the presence of hyphae was detected. This is
evidenced by a ,25 fold reduction in the percent of dorsal
epithelium that stains positive for neutrophils in Nlrc42/2 mice
when compared to WT (Figure 4). Nlrp32/2 and Asc2/2 mice
showed a ,3 fold decrease in positive staining (Figure 4). These
findings indicate that the activation of Nlrc42/2 is required for
neutrophil recruitment into infected tissues and proper trafficking
to the site of active fungal infection.
Mucosal IL-17 responses to Candida are dependent on
both NLRP3 and NLRC4
Recent reports have implicated the IL-17 family as a critical
mediator of protective host responses to a range of extracellular
pathogens, including Candida [41–45]. To assess the impact of
Figure 1. Regulation of Nlrp3 and Nlrc4 expression in mucosal candidiasis. Induction of inflammatory genes in buccal mucosal tissues from
WT, Nlrc4 2/2, Nlrp3 2/2, and Asc 2/2mice after 72 h of infection with Candida albicans. (A) NLRP3, (B) NLRC4, (C) mIL-1b, (E) mIL-1R1, and (F) mIL-1Ra.
All genes normalized to GAPDH. (D) Circulating IL-1b levels were determined by ELISA on serum samples pooled from N$3 animals. (*** P#0.001;
** P#0.01; * P#0.05)
doi:10.1371/journal.ppat.1002379.g001
Figure 2. NLRC4 inflammasome protects against mucosal overgrowth and prevents systemic dissemination of infection with
Candida albicans. (A) Quantitative fungal burden of tongues, and (B) kidneys ofNlrp32/2, Nlrc4 2/2, andWTmice after oral infection with C. albicans; (C)
Mean clinical severity score of Nlrp32/2, Nlrc4 2/2, andWTmice after 3, 7, 14 or 21d of infection. (D) Kaplan-Meier survival curve of WT and Nlrc42/2mice
infected with virulent C. albicans. (*** P#0.001; ** P#0.01; * P#0.05)
doi:10.1371/journal.ppat.1002379.g002
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inflammasome activation on IL-17 in our model of oral
candidiasis, we measured expression levels of IL-17 family
members in oral mucosal tissues after infection. A robust increase
in IL-17A and IL-17F gene expression was detected in the oral
mucosal tissue of WT animals, which was significantly reduced in
Nlrc42/2, Nlrp32/2, and Asc2/2 mice (Figure 5A, B). In contrast,
the induction of IL-17F was dependent on NLRP3, but not
NLRC4 or ASC (Figure 5B). A robust induction of interleukin 17A
receptor (IL-17RA) expression was detected in WT, Nlrp32/2, and
Asc2/2 mice while this response was abrogated in Nlrc42/2 mice
(Figure 5C). As many downstream inflammatory responses are
dependent on IL-17, the failure to upregulate the IL-17A receptor
may have implications for local anti-Candida inflammation and
chemotaxis of inflammatory cells.
Figure 3. NLRC4 inflammasome mediates neutrophil influx response to mucosal Candida infection. PASH stains of GDH2346 infected
tongues from (A) WT, (C) Nlrc42/2, (E) Nlrp32/2, and (G) Asc2/2. Tongue sections were stained with the neutrophil-specific NIMP antibody and DAPI
for (B) WT, (D) Nlrc42/2, (F) Nlrp32/2, and (H) Asc2/2. Magnified 40x images of sections are included.
doi:10.1371/journal.ppat.1002379.g003
Figure 4. Quantified neutrophil responses in Candida infected epithelium. Neutrophil influx into dorsal epithelium of WT, Nlrc42/2, Nlrp32/2,
and Asc2/2 mice was digitally quantified using MetaMorph software. Shown are percent ratios of fluorescent pixels (representing neutrophil staining)
over total pixels within a region containing the dorsal epithelium and submucosa of infected tongues.
doi:10.1371/journal.ppat.1002379.g004
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Inflammasome dependence of other inflammatory
cytokine responses in the oral mucosa following Candida
infection
We next examined expression of other inflammatory cytokines
in the oral mucosa of mice infected with Candida albicans. We
observed significantly lower induction of IL-18, another cytokine
requiring inflammasome mediated cleavage, in Nlrp32/2 and
Asc2/2 mice, while Nlrc42/2 mice showed a slight reduction
compared to WT which was not statistically different (Figure 5D).
As shown in Figure 5E, murine CXCL1, a homolog of human IL-
8, was dramatically induced in WT mice following Candida
infection and levels were significantly reduced in all strains of
inflammasome deficient mice. Induction of the pro-inflammatory
cytokine IL-6 was also significantly reduced in Nlrc42/2, Nlrp32/
2, and Asc2/2 mice compared to WT (Figure 5F).
Mucosal antimicrobial peptide responses to Candida
albicans infection
In addition to inflammatory cytokines responses following
pathogenic encounter, immune cells in the oral mucosa,
including epithelial cells, release small antimicrobial peptides
designed to disrupt microbial function as well as act as strong
chemoattractant signals for the migration of inflammatory cells
such as neutrophils and macrophages [46–48]. To better define
the inflammasome dependence of antimicrobial peptide re-
sponses in our murine model of OPC, we quantified several
murine beta-defensins as well as cathelicidin responses in the
oral mucosa following fungal infection. In contrast to murine
beta-defensin 1 (mBD1), which was not induced following
infection in any of the mice (Figure 6A), mBD2, -3, -and 4 all
showed elevated expression in oral tissues following Candida
infection in WT mice (Figure 6B, C, D). Reduced or negligible
up-regulation in mBD2 and mBD4 gene expression was
observed in all of the inflammasome deficient mice (Figure 6B,
D). In contrast, mBD3 induction was similar between WT and
Nlrc42/2 mice but significantly reduced in Nlrp32/2 and Asc2/2
mice (Figure 6C). No appreciable induction of mBD14, a
murine homolog of human beta-defensin 3, was observed in any
of the mice (Figure 6E). Another antimicrobial peptide,
cathelicidin or CAMP, has also been implicated as an activator
of the P2X7 receptor and a potential inducer of IL-1b release
from cells [49]. Expression levels of CAMP were dramatically
elevated in WT buccal tissue following Candida infection, and
this induction was dependent on NLRC4, NLRP3 and ASC
(Figure 6F).
Figure 5. Inflammasome dependence of inflammatory cytokine responses in the oral mucosa following Candida infection. Induction
of inflammatory genes in buccal mucosal tissues from WT, Nlrc4 2/2, Nlrp3 2/2, and Asc 2/2 mice after 72 h of infection with Candida albicans. (A)
mIL-17A, (B) mIL-17F, (C) mIL-17RA, (D) mIL-18, (E) mKC/CXCL1 and (F) mIL-6. All genes normalized to GAPDH. (*** P#0.001; ** P#0.01; * P#0.05).
doi:10.1371/journal.ppat.1002379.g005
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Figure 6. Antimicrobial peptide up-regulation in response to oral infection with Candida albicans is impaired in NLRP3, ASC and
NLRC4 - deficient mice. Expression of the antimicrobial peptides (A) murine b-defensin 1, (B) murine b-defensin 2, (C) murine b-defensin 3, (D)
murine b-defensin 4, (E) murine b-defensin 14, and (F) CAMP in buccal mucosal tissues from WT, Nlrc4 2/2, Nlrp3 2/2, and Asc 2/2 mice after 72 h of
infection with Candida albicans. (*** P#0.001; ** P#0.01; * P#0.05).
doi:10.1371/journal.ppat.1002379.g006
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NLRC4 functioning in the mucosa, compared to NLRP3 in
inflammatory cells, is critical for host defense against
mucosal colonization
NLRC4 does not appear to be involved in inflammasome
activation in innate immune cells exposed to Candida in vitro
[29,36,37]. Yet in our in vivo model on mucosal candidiasis,
NLRC4 is required for protection from mucosal colonization,
prevention of early dissemination of infection, and neutrophil
infiltration. Therefore, we hypothesized that the impact of
NLRC4 activation during fungal infection was manifested in
mucosal and/or stromal tissues versus hematopoietic cells. The
innate immune system is comprised of cells of embryonic origin,
including epithelial cells, as well as infiltrating leukocytes derived
from the bone marrow. To assess the contribution of different
inflammasome molecules in these compartments, we generated
bone marrow chimera mice and infected them orally with C.
albicans. Lethally irradiated recipient mice were reconstituted with
bone marrow progenitor cells and allowed to fully reconstitute
prior to infection. WT mice that were reconstituted with WT bone
marrow exhibited no increase in oral infection or systemic
dissemination of infection at 7 days when compared to non-
chimeric WT mice, indicating that the chimera procedure does
not predispose the mice to higher levels of fungal infection (Figure
S2). WT mice reconstituted with Nlrc42/2 bone- marrow showed
no significant difference in oral fungal colonization compared to
WT/WT chimera mice (Figure 7A). In contrast, Nlrc42/2 mice
reconstituted with WT bone marrow showed enhanced oral
colonization with C. albicans (Figure 7A), to a degree that is similar
to native Nlrc42/2 mice (Figure 2A). The Nlrc42/2 mice
reconstituted with WT bone marrow also exhibited increased
disease severity when compared to WT/WT chimera mice
(Figure 7C). These results demonstrate that intact NLRC4
function in the stromal or epithelial compartment is associated
with protection from mucosal infection with Candida albicans.
To evaluate the role of the NLRP3 inflammasome in the
stromal versus hematopoietic compartments, bone marrow
chimeras were generated using Nlrp32/2 as well as Asc2/2 mice.
Nlrp32/2 mice receiving WT bone marrow showed difference in
oral fungal burdens relative to WT/WT chimera controls
(Figure 7A). However, WT mice reconstituted with Nlrp32/2
bone marrow exhibited significantly elevated oral infection when
compared to WT/WT chimera mice (Figure 7A), although both
sets of NLRP3 chimera mice showed elevated clinical scores
compared to WT/WT chimera mice (Figure 7C). A similar
pattern was seen with ASC chimeric mice (Figure 7A), where
higher oral fungal colonization was observed in the WT mice
receiving ASC deficient bone marrow compared to Asc2/2 mice
receiving WT cells or WT/WT chimera mice. These observations
indicate that the function of the NLRP3/ASC inflammasome
complex in infiltrating inflammatory cells is critical for control of
oral mucosal infection.
NLRP3 inflammasome expression in both hematopoietic
and stromal cell lineages is required for protection
against dissemination of mucosal infection with C.
albicans
We next assessed the role of NLRC4 and NLRP3 in protection
from systemic dissemination of infection. As a marker of
dissemination, we quantified the fungal burdens of the kidneys
in bone marrow chimera mice infected with C. albicans for 7 days.
As shown in Figure 7B, neither Nlrc42/2 donor nor recipient
chimera mice showed dissemination to the degree seen in native
Nlrc42/2 mice (Figure 2B), although a trend towards increased
dissemination was observed compared to WT/WT chimera mice.
In contrast, both Nlrp32/2 donor and recipient chimera mice
showed higher systemic dissemination when compared to WT/
WT chimera mice (Figure 7B). WT mice receiving Asc2/2 bone
marrow showed enhanced dissemination of infection, whereas
Asc2/2 mice receiving WT bone marrow showed similar kidney
fungal burdens to WT/WT chimera mice (Figure 7B). These
results demonstrate that the NLRP3/ASC inflammasome plays a
dominant role in protection against disseminated fungal infection
compared to the NLRC4 inflammasome which plays a role in
protection of the host from mucosal infection.
Discussion
Disseminated fungal infections present a significant health risk
to both immune-competent and -compromised individuals,
making studies into early host immune responses involved in the
prevention of dissemination critical for the development of new
therapeutic approaches. The release of inflammatory mediators
from resident cells at the site of infection is critical for
antimicrobial responses including the recruitment of inflammatory
cells such as neutrophils and macrophages. IL-1b has been
implicated in protective host immune responses to a range of
infectious pathogens including viruses, bacteria, and fungi [11].
We and others have previously shown that the NLRP3
inflammasome is important for control of Candida infection in
both mucosal and disseminated models [6,29,36,37]. Here we
present the first experimental evidence implicating the NLRC4
inflammasome in the induction of protective host responses to
challenge by a fungal pathogen. Our studies reveal that the
NLRC4 inflammasome is important for the control of Candida
albicans infection in vivo, particularly in the oral cavity, with
increased oral fungal colonization and disease severity observed in
Nlrc42/2 mice. Lack of NLRC4 also increased susceptibility to
disseminated fungal infection, particularly early in infection. Our
model of OPC using a clinical isolate recapitulates human oral
infections in which mortality is rarely observed. We carried out
OPC infection studies using a highly virulent strain of C. albicans
(ATCC 90234) and observed similar increases in oral colonization
and dissemination at 7d to that observed using the oral isolate
GDH2346 (Figure S1). However, the virulent strain resulted in
significant mortality in Nlrc42/2 mice when compared to WT
(Figure 2E). When we examined cellular infiltrations in infected
tongues, we observed a substantial impact in both cellular
infiltration, and specifically neutrophil-influx in the absence of
NLRC4, compared to a robust neutrophil infiltration into the
infected epithelium of WT mice. Interestingly, the neutrophils that
were present in the Nlcr42/2 tongue remained in the sub-mucosa.
This defect in neutrophil infiltration into the epithelium of the
tongue may explain the extended defect in oral clearance observed
in Nlrc42/2 mice throughout the course of our OPC infection
studies. The importance of neutrophils in anti-fungal defenses is
well known. Recent studies have shown that the innate
inflammatory mileu is critical for effective neutrophil activity
against fungal pathogens including IL-6, GM-CSF, and IL-17
responses [38,41,42,50,51].
In order to better define the molecular basis for protection from
mucosal infection, we evaluated a panel of innate inflammatory
responses in the oral mucosa from Candida infected mice. Previous
studies have demonstrated that NLRP3 expression is inducible
following infection and implicate this as the rate limiting step in
inflammasome activation [52,53] but little is known about the
regulation of NLRC4 expression. IL-1b has been shown to
increase the expression level of other pro-inflammatory cytokines
NLRC4 Inflammasome in Mucosal Candidiasis
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following IL-1 receptor engagement [54-56], and IL-1 receptor
activation may result in the increased expression of inflammasome
proteins in the responding cells, priming them for quick activation.
We show that Candida infection up-regulates NLRP3 and NLRC4
expression in mucosal tissues compared to mock infected mice.
Additionally, we demonstrate that this induction is impaired in
Nlrp32/2, Asc2/2 and Nlrp42/2 mice. As expected, ASC
expression was found to be constitutive and not induced by
Candida infection (data not shown). Our data provides novel insight
into transcriptional changes induced by activation of inflamma-
some complex by an infectious pathogen. The impairment of
mucosal NLRP3 induction in NLRC4 deficient mice may enhance
the impact of the lack of this receptor on susceptibility to mucosal
infection.
As expected, we found that IL-1b was up-regulated in wild-type
mice in response to fungal infection. However, these responses
were partially abrogated in NLRC4 deficient mice and absent in
NLRP3 and ASC deficient mice. Similarly, the IL-1 receptor 1
(IL1R1) and IL-1 receptor antagonist (IL1Rn) were poorly
induced by Candida infection in WT and inflammasome deficient
mice. Consistent with published studies, we did not observe a role
for the NLRC4 inflammasome in IL-1b induction or processing in
inflammatory cells stimulated in vitro with Candida albicans
[29,36,37].
IL-18 is another member of the IL-1 family which requires
proteolytic enzyme cleavage for activation [57,58]. Although
caspase-1 mediated cleavage of pro-IL-18 into the bioactive form
is the accepted paradigm, alternative mechanisms for cleavage
have been proposed including PR3, granzyme B and mast cell
chymase [59,60]. In our studies, in vivo IL-18 induction by Candida
infection showed a similar pattern in mucosal tissues as IL-1b.
Next, we investigated the regulation of the cytokine IL-17, which
has been shown to play a role in anti-fungal immunity in humans
and in animal models [41,42,44,45]. In response to infection with
Candida albicans, IL-17A, IL-17F and IL-17RA were up-regulated
in mucosal tissues. Interesting patterns of induction of the IL-17
family by Candida infection were observed; IL-17A was dependent
on NLRC4, NLRP3 and ASC whereas IL-17F was only
dependent on NLRP3 with comparable induction seen in WT,
NLRC4 and ASC deficient mice. The induction of IL-17RA was
only dependent on NLRC4. The inflammasome dependence of
IL-17 family responses during microbial infection is not well
understood, and the regulation of these genes is likely multi-
factorial, including dependence on IL-1b as well as other
inflammatory mediators. The cytokine IL-6 was induced in wild-
type mice in response to Candida infection but was significantly
reduced in NLRC4 deficient mice and completely abrogated in
NLRP3 and ASC deficient mice. The chemokine KC (CXCL1), a
murine homolog of human IL-8, was also found to be highly
dependent on IL-1b as NLRC4, NLRP3, and ASC deficient mice
exhibited significant decreases in gene expression following fungal
challenge. Although IL-6 and KC/IL-8 are not known to be major
mediators of anti-fungal immunity, they play an important role in
the cytokine network of innate cellular communication. IL-6 has
been shown to be directly up-regulated in macrophages by Candida
cell wall components [61] but can also be induced by secondary
effect of other inflammatory responses. IL-6 signaling has also
been shown to be important in the recruitment of neutrophils in
response to Candida [38,62]. IL-6 production is regulated by a
complex network of signaling pathways that include NF-kB as well
as a newly described pathway mediated by the protein tyrosine
phosphatase, Src homology domain 2-containing tyrosine phos-
phatase-1 (SHP-1) leading to activation of Erk1/2–C/EBPb [63].
This is particularly relevant to mucosal anti-fungal immunity as
SHP-1, also known as PTPN6 and PTP1C, has been shown to
negatively regulate the effects of epidermal growth factor [64], an
important regulator of epithelial homeostasis, as well as affect tight
junction formation in epithelium [65]. We propose, based on our
histological analysis, that the defect in the induction of
inflammatory mediators observed in mice deficient in the
NLRP3/ASC inflammasome is most likely due to defective
functioning of inflammatory leukocytes in the absence of these
proteins. In contrast, the partial defect in inflammatory responses
observed in mucosal tissues from infected NLRC42/2 mice is
likely due to impaired infiltration of immune cells into infected
tissue.
Another key innate immune response during infection is the
release of antimicrobial peptides designed to limit pathogen
growth and survival. Antimicrobial peptides (AMPs) consist of a
diverse group of small cationic peptides including the defensins,
cationic and amphipathic peptides which have broad antimicro-
bial and chemotactic properties. Beta-defensins are primarily
secreted by epithelial cells and play an important role in the
microbial homeostasis of the skin, oral cavity, lung and gut.
Human b-defensin (hBD)-1 is primarily expressed in the urinary
and respiratory tracts [66,67] and although constitutively
expressed, may be up-regulated by infection or inflammation. A
defect in hBD-1 activity in the lung has been associated with cystic
fibrosis [68,69]. Polymorphisms in the defensin-1 gene, defB1, have
been associated with low oral colonization with Candida albicans
(Jurevic 2003), protection from HIV [70–72], chronic obstructive
pulmonary disease [73] and Crohn’s disease [74]. The murine
homolog of hBD-1, murine b-defensin (mBD)-1, is also expressed
by epithelial surfaces, lung and kidney and has salt sensitive
antimicrobial activity [75], although its role in antifungal defense is
unclear. Both hBD-2 and hBD-3 have known anti-Candida [46,76–
78] as well as anti-HIV activity [79,80]. The role of mBD-2, the
murine homolog of hBD-2, in oral mucosal health is unclear
although its expression in the lung is highly inducible by LPS [81].
The murine ortholog of hBD-3, mBD-14, has inducible expression
in the respiratory and intestinal tracts as well as in dendritic cells
and shows anti-bacterial and chemotactic activity [82]. To better
define the role of AMPs in anti-fungal defense, we examined AMP
responses in oral mucosa after infection with Candida albicans. We
show that mBD-1 appeared to be constitutively expressed in WT
mice; however, gene expression was inhibited in NLRP3 and ASC
deficient mice. We discovered that mBD-2, -4 and -14 were highly
dependent on inflammasome activation as both NLRC4 and
NLRP3 as well as ASC deficient mice exhibited dramatically
reduced expression levels compared to WT. Interestingly, mBD-3
responses were found to have little dependence on NLRC4 but
were dependent on NLRP3 and ASC. Another class of AMPs, the
cathelicidins, consisting of human LL-37 and murine CAMP (also
known as CRAMP), are known to have anti-Candida as well as
chemotactic activity [83–87]. We observed that CAMP was highly
up-regulated in WT mucosa in infected mice, but not in NLRC4,
Figure 7. NLRC4 activity in somatic tissues, in contrast to NLRP3 in both hematopoietic and stromal compartments, controls oral
infection with Candida albicans. Quantitative fungal burden of (A) tongues and (B) kidneys of WT, Nlrc4 2/2, Nlrp3 2/2, Asc 2/2 bone marrow
chimera mice after oral infection with C. albicans; (C) Mean clinical severity score of WT, Nlrc4 2/2, Nlrp3 2/2, Asc 2/2 bone marrow chimera mice after
7d of infection. (*** P#0.001; ** P#0.01; * P#0.05).
doi:10.1371/journal.ppat.1002379.g007
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NLRP3 or ASC deficient mice. A recent report found that IL-17A
augmented vitamin D3-mediated CAMP production in keratino-
cytes during psoriasis [88]. In concurrence with these findings, we
observed abrogated CAMP expression in NLRC4 and NLRP3
deficient mice, which also lacked IL-17A gene expression,
following Candida challenge. In addition to its direct antimicrobial
effects, CAMP has been identified as a modulator of the P2X7R
which has a known role in ATP-induced IL-1b release [49,89,90].
From our studies, it can be inferred that initial production of IL-1b
may induce IL-17A and CAMP production which can in turn
positively regulate further production of IL-1b to create an
inflammatory environment which limits fungal infection. This
mechanism may serve to explain the strong in vivo phenotype
observed in our model for NLRC4 and NLRP3 deficient mice,
perhaps via a failure to engage this positive feedback loop resulting
in an immune state that is prone to persistent infection. In addition
to driving IL-1b and IL-18 responses, the NLRC4 inflammasome
has been shown to induce a specialized form of programmed cell
death, termed pyroptosis or pyronecrosis, characterized by the
release of cytoplasmic contents, which include inflammatory
mediators such as ATP and arachidonic acid metabolites, to the
extracellular matrix. A defect in pyroptosis may partially account
for the critical role for NLRC4 activation in our model of
candidiasis and provides an opportunity for future research.
Interestingly, our data shows that activation of the NLRC4
inflammasome is important in the stromal compartment, where its
role is critical for in vivo anti-fungal host defense, but not in the
hematopoietic compartment. Using bone marrow chimera mice
we differentiated between inflammasome activity in hematopoietic
derived cells such as infiltrating macrophages and neutrophils, and
embryonic derived mucosal tissues in our model of oropharyngeal
candidiasis. This approach demonstrated that NLRP3 and ASC
activity in both hematopoietic and stromal compartments are
important for protection against oral infection and dissemination.
This is in agreement with our previously published findings that
the NLRP3 inflammasome was the primary mediator of IL-1b
cleavage in murine macrophages stimulated with Candida in vitro
[6]. In contrast, in vivo infection of bone marrow chimera mice
showed higher mucosal colonization in NLRC4 deficient recipient
mice reconstituted with WT inflammatory cells than WT
recipients reconstituted with Nlrc4-/- cells, which had similar levels
of oral mucosal infection as WT controls. Overall, these studies
utilizing chimera mice in our murine model of mucosal fungal
infection implicate a novel, tissue-specific role for the NLRC4
inflammasome.
Many key questions are raised by the findings in this paper.
Known microbial activators of the NLRC4 inflammasome include
Salmonella typhimurium [91], Shigella flexneri [92,93], Legionella
pneumophila [94] and Pseudomonas aeruginosa [34]. Previous reports
implicated the activation of NLRC4 by the release of flagellin
through the Type-III secretion apparatus and by components of
the basal rod proteins of the Type III secretion system itself
[93,95,96]. Despite these findings, it still remains unclear the
mechanism by which NLRC4 senses these activators. Given the
homology between the known bacterial activators of NLRC4, it is
possible that these proteins may function as a direct receptor
recognizing a conserved sequence or structural feature. Current
models of NLRP3 activation indicate it does not act as a
traditional receptor but rather as a nexus for different pathways
invoked following cellular injury and/or infection, which may also
be true for the NLRC4 inflammasome. Future studies will seek to
elucidate the mechanism of NLRC4 recognition of its activators
and also identify the molecule(s) in Candida that induce NLRC4
activation. We hypothesize that mucosal NLRC4 activation may
occur as an early event in fungal infection, perhaps as a result of
cellular damage or direct effect of infection, leading to the
induction of innate responses such as anti-microbial peptides and
cytokines that recruit inflammatory cells including neutrophils and
macrophages that infiltrate the sites of infection. Candida induced
activation of the NLRP3/ASC inflammasome then provides a
critical amplification of the innate response leading to protection
of the host from overwhelming mucosal and disseminated
candidiasis.
Materials and Methods
Ethics statement
The animals described in this study were housed in the
AAALAC accredited facilities of the Case Western Reserve
University School of Medicine. All animal use protocols have
been approved by the Institutional Animal Care and Use
Committee of Case Western Reserve University and adhere to
national guidelines published in Guide for the Care and Use of
Laboratory Animals, 8th Ed., National Academies Press, 2001.
Fungal preparations
Candida albicans strains GDH2346 (NCYC 1467), a clinical strain
originally isolated from a patient with denture stomatitis, or
ATCC 90234 were utilized for in vitro and in vivo studies. Master
plates were maintained on Sabouraud Dextrose (SD) agar. For
OPC infection, yeast were grown for 12–16 h in SD broth,
pelleted at 3000 rpm for 5 min and washed 2x with sterile 1X
PBS. Yeast cells were manually counted using a hemocytometer
and diluted to 56107 cells/mL for live infection.
Murine model of oral Candida albicans infection
Wild-type C57BL/6 mice were purchased from Jackson
Laboratories. Nlrp32/2, Nlrc42/2 and Asc2/2 mice were gener-
ated by Millenium Pharmaceuticals. Animals were housed in filter-
covered micro-isolator cages in ventilated racks. Infection and
organ harvesting was performed as described previously [6].
Briefly, after pre-treatment with antibiotic containing water, the
mice were anesthetized and light scratches made on the dorsum of
the tongue following by the introduction of 56106 C. albicans yeast.
The scratches are superficial, limited to the outermost stratum
corneum, and do not cause trauma or bleeding. After infection of
3 to 21 d, the mice were euthanized, organs harvested and
homogenized and fungal burdens assessed by growth on SD agar.
For gross clinical score assessment, visual inspection of fungal
burdens on the tongues was performed under a dissection
microscope. A score of 0 indicates the appearance of a normal
tongue, with intact light reflection and no visible Candida, a score of
1 denotes isolated patches of fungus, a score of 2 when confluent
patches of fungus are observed throughout the oral cavity, and a
score of 3 indicates the presence of wide-spread fungal plaques and
erosive mucosal lesions.
RNA extraction
For assessment of inflammatory gene induction, buccal tissue
was isolated from infected mice and immediately placed into a
RNA stabilization reagent (RNAlater, Qiagen). After homogeni-
zation in lysis buffer for 1.5 min using a bead-beater homogenizer
(Retsch), total RNA was isolated using PrepEase RNA Spin Kit
(USB/Affymetrix) followed by conversion to cDNA using
SuperScript III Reverse Transcriptase (Invitrogen). Whole blood
was collected via retro-orbital bleeding into EDTA pre-coated
tubes, followed by centrifugation and removal of serum. Serum
was stored at 280uC until used.
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Quantitative real-time PCR and enzyme-linked
immunosorbent assay
Quantitative real-time PCR was done as described [6]. Specific
primer sequences are listed in Table S1. Cytokines were measured
in serum by ELISA (R&D). NCBI gene accession numbers are as
follows: Nlrc4:NM_001033367.3; Nlrp3: NM_145827.3; Asc:
NM_023258.4; Il1b: NM_008361.3; Il1r1: NM_008362.2; Il1rn:
NM_031167.5; Il17a: NM_010552.3; Il17f: NM_145856.2; Il17ra:
NM_008359.2; Il18: NM_008360.1; Cxcl1: NM_008176.3; Il6:
NM_031168.1; Defb1: NM_007843.3; Defb2:NM_010030.1; Defb3:
NM_013756.2; Defb4: NM_019728.4; Defb14: NM_183026.2;
Camp: NM_009921.2.
Histology
Intact tongues are removed at necropsy, immediately immersed
in Tissue Freezing Medium (EMS) and flash frozen in liquid
nitrogen. After cryo-sectioning, 5 mm sections were fixed with10%
formalin for 2 min then stained with Periodic Acid Schiff and
Hematoxylin (PAS/H). For immunofluorescent staining, the
sections were blocked with 5% normal goat serum/PBS, stained
with rat monoclonal anti-neutrophil primary antibody (NIMP-
R14; specific for Ly-6G and Ly-6C) and Alexa Fluor 488-
conjugated goat anti-rat secondary antibody (Invitrogen) and
mounted in Vectashield containing DAPI (Vector Laboratories).
For quantitative analysis, images were taken using a Leica DMI
6000B inverted microscope, and the number of neutrophils in
each section was digitally quantified using the imaging program
MetaMorph (Molecular Devices). Briefly, the number of pixels in a
region containing the dorsal epithelial portion of the tongue was
counted. A threshold value was then assigned which corresponds
to a minimum fluorescent value of a neutrophil. The number of
pixels at or above this threshold was determined and a percentage
of fluorescent pixels determined by dividing by total overall
number of pixels.
Generation of chimera mice
Lethally irradiated mice (exposed to a Cesium-139 c-radiation
source for a total full body dose of 900 rads) received 56106 bone
marrow cells from pooled donor mice via tail vein injection and
allowed to recover for 4 weeks.
Statistical analysis
Data were analyzed using commercial software (GraphPad) and
Student’s two-sample independent t tests or Mann Whitney U tests
were used for comparative statistical analysis of qPCR, ELISA,
and quantitative fungal load data. Comparison of survival curves
was done using a mean Logrank test. P values are presented when
statistical significance was observed (significance set at P#0.05 at a
confidence interval of 95%).
Supporting Information
Figure S1 Quantitative fungal burdens of gastrointesti-
nal tissues from WT and Nlrc4 deficient mice infected
orally with Candida albicans. WT or Nlrc42/2 mice were
infected 7 days. Fungal burdens were determined for (A)
esophagus, (B) stomach, (C) duodenum, (D) jejunum, and (E)
ileum. (F) Kaplan-Meier survival plot of WT and Nlrc42/2 mice
following GDH2346 infection. (G) Quantitative fungal burden of
tongues and kidneys of WT and Nlrc42/2 mice infected for 7d
with virulent C. albicans 90234 strain. (*** P # 0.001; ** P # 0.01;
* P # 0.05).
(EPS)
Figure S2 WT-WT chimera mice exhibit similar infec-
tion levels to WT non-irradiated WT controls. Fungal
burdens were determined (A) tongue and (B) kidneys. (C) Gross
Clinical score was used as a measure of disease severity.
(EPS)
Table S1 Primers used for measurement of gene up-
regulation by real-time PCR. List of forward and reverse gene
specific primers, and PCR product size, used in quantitative real-
time PCR.
(TIFF)
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